Drug profile · INN
inamrinone lactate
INOCOR
inamrinone lactate (INOCOR) is a phosphodiesterase 3a inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — inamrinone lactate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
inamrinone lactate (INOCOR) is a phosphodiesterase 3a inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Phosphodiesterase 3A inhibitor
Primary target: cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is inamrinone lactate?
inamrinone lactate (INOCOR) is a phosphodiesterase 3a inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for inamrinone lactate?
INOCOR is a marketed brand name for inamrinone lactate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of inamrinone lactate?
inamrinone lactate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.